NCCN Launches 3D Virtual Simulator Learning Platform

NCCN has launched a 3D Virtual Metastatic Colorectal Cancer (mCRC) Simulator Learning Platform as part of the NCCN Continuing Education Program. To develop the 3D Virtual mCRC Simulator Learning platform, NCCN collaborated with Syandus, Inc., a technology company specializing in development of experiential learning platforms for health care professionals and other learners.

“NCCN is pleased to announce the availability of the 3D Learning Simulator,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “This platform is a virtual, 3-dimensional, real-world vision that provides participants with an engaging and self-correcting learning atmosphere.”

Based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon and Rectal Cancers, the simulator enables users to virtually work through the continuum of care approach to CRC in a risk-free environment with increasingly complex clinical presentations, and features new clinical data and emerging agents.

The NCCN 3D Virtual Simulator Platform tracks progress throughout the simulation of scenarios as users walk through the steps of treating virtual patients, providing immediate feedback on clinical choices, and providing an opportunity to reflect and revise approaches to treatment. Users who successfully complete 8 scenarios will earn a certificate and 3 continuing education credits. This education is provided at no cost to learners.

Principal faculty for the simulator are the Chair and Vice-Chair of the NCCN Guidelines Panels for Colon and Rectal Cancers, Al B. Benson, III, MD, Professor of Medicine at Northwestern University Feinberg School of Medicine, and Associate Director for Clinical Investigations at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and Alan P. Venook, MD, The Madden Family Distinguished Professor of Medical Oncology and Translational Research, UCSF Helen Diller Family Comprehensive Cancer Center, respectively.

A virtual learning platform for multiple myeloma is expected to launch in 2015.

For more information about the NCCN 3D Virtual mCRC Simulator Learning Platform, visit

Free NCCN Pocket Guidelines Available for Antiemesis and Myelodysplastic Syndromes

NCCN is pleased to offer a pocket-sized version of the NCCN Guidelines for Antiemesis and Myelodysplastic Syndromes. These printed versions of the NCCN Guidelines are conveniently sized to fit in a lab coat pocket and serve as a valuable reference for physicians, nurses, pharmacists, and other oncology health care professionals.

These pocket guidelines booklets are printed on quality gloss stock for durability and have coil spines so that algorithms can be viewed as 2-page spreads. Content is formatted in sections with colored tabs so readers can quickly and easily reference desired sections.

Thanks to generous sponsorship, NCCN will supply and ship up to 5 copies of the NCCN pocket guidelines to requestors for free. Larger quantities are also available for distribution at NCCN Member Institutions. To request larger quantities, please contact

NCCN pocket guidelines are available for free while supplies last. To order, visit

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 90 59 2
PDF Downloads 80 33 6
EPUB Downloads 0 0 0